Genes and Diseases (Jul 2024)
SUV39H1-driven NFATc1 methylation is essential for the c-Cbl-mediated degradation of NFATc1 in an osteoclast lineage
- Do-Won Jeong,
- Hye-Jin Kim,
- Jong-Wan Park,
- Seulbee Lee,
- Hyeryeon Jung,
- Eugene C. Yi,
- Nacksung Kim,
- Yang-Sook Chun
Affiliations
- Do-Won Jeong
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Physiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
- Hye-Jin Kim
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Physiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
- Jong-Wan Park
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
- Seulbee Lee
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Physiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
- Hyeryeon Jung
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine Or College of Pharmacy, Seoul National University, Seoul 03080, Republic of Korea
- Eugene C. Yi
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine Or College of Pharmacy, Seoul National University, Seoul 03080, Republic of Korea
- Nacksung Kim
- Department of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Republic of Korea
- Yang-Sook Chun
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Physiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Corresponding author. Department of Biomedical Sciences Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.
- Journal volume & issue
-
Vol. 11,
no. 4
p. 101034